Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Organovo Holdings ( (ONVO) ) is now available.
On April 23, 2025, Organovo Holdings, Inc. announced it will transition its 3D bioprinting and legacy technology to a new entity, VivoSim Labs, Inc., effective April 24, 2025. The company’s stock will trade under the new ticker symbol ‘VIVS’ on the Nasdaq Capital Market, but no action is required from existing stockholders. This strategic move reflects a rebranding effort to enhance its market presence and streamline its operations.
More about Organovo Holdings
Organovo Holdings, Inc. operates in the biotechnology industry, focusing on 3D bioprinting technology. The company is known for its innovative approach to creating functional human tissues, which has implications for drug discovery and regenerative medicine.
YTD Price Performance: -63.59%
Average Trading Volume: 735,064
Technical Sentiment Signal: Strong Buy
Current Market Cap: $3.42M
See more data about ONVO stock on TipRanks’ Stock Analysis page.